About
Adrian K. McKemey, Ph.D., has served as President of Certara Drug Development Solutions since March 2025. Before joining Certara he was Head of Enterprise Transformation at IQVIA from 2022 to 2025 and, from 2016 to 2022, Senior Vice President and Head of R&D Strategy Solutions at IQVIA (formerly Quintiles), and earlier a Principal in the Life Sciences practice at The Boston Consulting Group. He holds a B.S. with First Class honors and a Ph.D. in high energy nuclear particle physics from the University of London.
Roles
Certara, Inc.
President, Certara Drug Development Solutions · Current role
2025–present
IQVIA
Head of Enterprise Transformation (2022-2025)
—
IQVIA (Quintiles)
SVP & Head of R&D Strategy Solutions (2016-2022)
—
The Boston Consulting Group
Principal, Life Sciences practice
—
IQVIA
Head of Enterprise Transformation
—
Quintiles (IQVIA)
SVP, R&D Strategy Solutions
—
The Boston Consulting Group
Principal, Life Sciences
—
Fixed Compensation
FY 2025Salary
$366,667
ComponentAnnual base salary
Sign-on bonus
$466,000
ComponentContractual sign-on cash bonus
All other compensation
$5,026
Component401(k) match, insurance and perquisites
Total compensation
$1,855,823
Performance Compensation
Data from FY 2025Cash incentive
Annual incentive bonus
$161,172
FormCash
Target Opportunity
—
PlanAnnual Incentive Bonus (AIB) Plan
Evaluation periodFY2025
Stock awards
Long-term equity awards
$856,958
FormRSUs (40%) and PSUs (60%) under 2020 Incentive Plan
ValuationGrant date fair value (ASC 718), PSUs at target
Also at Certara, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.